Mahmoudi, Javad <br/><br/>
Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats.  [electronic resource] 

 -  Pharmacological reports : PR  2011 
 - 908-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2299-5684 
<br/><br/><label>Standard No.: </label>10.1016/s1734-1140(11)70606-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Buspirone--administration & dosage<br/>Catalepsy--chemically induced<br/>Dose-Response Relationship, Drug<br/>Injections, Intraperitoneal<br/>Levodopa--adverse effects<br/>Male<br/>Oxidopamine--toxicity<br/>Parkinsonian Disorders--drug therapy<br/>Rats<br/>Rats, Wistar<br/>Serotonin 5-HT1 Receptor Agonists--administration & dosage<br/>Time Factors